<sup>18</sup>F-FDG dose reduction using deep learning-based PET reconstruction.
Authors
Affiliations (5)
Affiliations (5)
- Department of Diagnostic Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. [email protected].
- Department of Radiology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
- Center for Radiation Disaster Medical Science, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
- Department of Diagnostic Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
- CT Systems Development Department, Canon Medical Systems Corporation, 1385 Shimoishigami, Otawara City, Tochigi, 324-8550, Japan.
Abstract
A deep learning-based image reconstruction (DLR) algorithm that can reduce the statistical noise has been developed for PET/CT imaging. It may reduce the administered dose of <sup>18</sup>F-FDG and minimize radiation exposure while maintaining diagnostic quality. This retrospective study evaluated whether the injected <sup>18</sup>F-FDG dose could be reduced by applying DLR to PET images. To this aim, we compared the quantitative image quality metrics and the false-positive rate between DLR with a reduced <sup>18</sup>F-FDG dose and Ordered Subsets Expectation Maximization (OSEM) with a standard dose. This study included 90 oncology patients who underwent <sup>18</sup>F-FDG PET/CT. They were divided into 3 groups (30 patients each): group A (<sup>18</sup>F-FDG dose per body weight [BW]: 2.00-2.99 MBq/kg; PET image reconstruction: DLR), group B (3.00-3.99 MBq/kg; DLR), and group C (standard dose group; 4.00-4.99 MBq/kg; OSEM). The evaluation was performed using the signal-to-noise ratio (SNR), target-to-background ratio (TBR), and false-positive rate. DLR yielded significantly higher SNRs in groups A and B than group C (p < 0.001). There was no significant difference in the TBR between groups A and C, and between groups B and C (p = 0.983 and 0.605, respectively). In group B, more than 80% of patients weighing less than 75 kg had at most one false positive result. In contrast, in group B patients weighing 75 kg or more, as well as in group A, less than 80% of patients had at most one false-positives. Our findings suggest that the injected <sup>18</sup>F-FDG dose can be reduced to 3.0 MBq/kg in patients weighing less than 75 kg by applying DLR. Compared to the recommended dose in the European Association of Nuclear Medicine (EANM) guidelines for 90 s per bed position (4.7 MBq/kg), this represents a dose reduction of 36%. Further optimization of DLR algorithms is required to maintain comparable diagnostic accuracy in patients weighing 75 kg or more.